| "Micrococcus niger" Hall 1930| ATCC 27731| DSM 20475| JCM 6506| Micrococcus niger| NCTC 11805| Peptococcus niger| Peptococcus niger (Hall 1930) Kluyver and van Niel 1936
Normal Gut Microbiota: Peptococcus species, including Peptococcus niger, are part of the normal microbial community in the human gastrointestinal tract. They contribute to the complex ecosystem of microorganisms that inhabit the gut.
Anaerobic Bacteria: Peptococcus niger, like other Peptococcus species, is an anaerobic bacterium, meaning it thrives in environments with little to no oxygen. Anaerobic bacteria are common inhabitants of the gut microbiota.
Fermentation: Peptococcus species are known for their ability to ferment various substrates. In the anaerobic conditions of the gut, these bacteria can participate in the breakdown of organic compounds through fermentation processes.
Limited Information on Health Impacts: Specific information about the health impacts of Peptococcus niger, both positive and negative, is not extensively documented. While these bacteria are generally considered part of the normal gut microbiota and may contribute to the fermentation of dietary components, details about their specific roles and effects on health may be limited.
Microbial Interactions: Bacteria within the Peptococcus genus, including P. niger, interact with other members of the gut microbiota and with the host. These interactions are complex and contribute to the overall balance and functionality of the gut microbiome.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.44 | 20 | 350 | 0 | 333 | 104.9 | 44 | 116.3 | 20 | 350 | 8.3 %ile | 83.3 %ile | ||
biomesight | 91.24 | 770 | 110 | 859 | 0 | 2309 | 569.7 | 340 | 887.5 | 0 | 1020 | 9.9 %ile | 90.9 %ile | |
thorne | 48.28 | 1 | 20 | 0 | 19 | 6.8 | 6 | 6 | 1 | 20 | 6.3 %ile | 87.5 %ile | ||
thryve | 40.07 | 0 | 23 | 1 | 191 | 0 | 6343 | 522.5 | 43 | 2969.8 | 1 | 185 | 0 %ile | 91.8 %ile |
ubiome | 2.03 | 21 | 1341 | 0 | 1230 | 299.8 | 72 | 474.5 | 21 | 1341 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 0 | 1.67 | 0 | 0.0002 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 97.696 % | 0.058 % | 0.087 % | 2798.0 | 2864 |
BiomeSightRdp | 21.875 % | 0.008 % | 0.009 % | 7.0 | 32 |
custom | 6.78 % | 0.015 % | 0.014 % | 4.0 | 59 |
Medivere | 14.286 % | 0.004 % | % | 1.0 | 7 |
Thorne | 28.889 % | 0 % | 0.001 % | 26.0 | 90 |
Thryve | 38.901 % | 0.055 % | 0.277 % | 538.0 | 1383 |
uBiome | 2.02 % | 0.03 % | 0.047 % | 16.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.